Bellicum Pharmaceuticals

Bellicum Pharmaceuticals develops controllable cellular immunotherapies for cancer using its CID platform. 

Domain
Healthcare
Status
IPO’d/​Acquired
IPO Date
2014
Stage of Initial Investment
Series C
Initial Investment Year
2014